Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CMAB009

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BackgroundThe 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX) regimen is the standard first-line treatment for metastatic… Expand
Is this relevant?
2017
2017
3513Background: More efficient second line treatment regimen for mCRC is urgently needed. CMAB009, a recombinant human/mouse… Expand
Is this relevant?
2011
2011
In the present study, we conducted a Phase 1 study of a recombinant anti-EGFR monoclonal antibody (CMAB009) that has the same… Expand
Is this relevant?
2011
2011
OBJECTIVE To characterize the safety profiles and serum pharmacokinetic effects of anti-epidermal growth factor receptor… Expand
Is this relevant?